Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Host immune cells and tissues via paracrine factors, cell-cell contact, and extracellular vesicles" describes a complex physiological interface rather than a single molecular target. It refers to the collective biological system—comprising immune cell subsets like T cells, macrophages, and dendritic cells, as well as the surrounding tissue architecture—that responds to therapeutic interventions such as Mesenchymal Stem Cells (MSCs) or extracellular vesicle (EV) therapies (Galipeau & Sensébé, 2018). These therapies exert their effects through three primary modalities: the secretion of soluble paracrine mediators (e.g., cytokines and growth factors), direct physical cell-cell contact (e.g., PD-L1/PD-1 interactions), and the release of EVs that transport proteins and nucleic acids to recipient cells (Wiklander et al., 2019). This multi-faceted interaction is critical for achieving immunomodulation and promoting tissue repair in conditions such as graft-versus-host disease, Crohn's disease, and various inflammatory disorders (Pittenger et al., 2019). Because it involves a systemic network of interactions, it is often characterized as a "systemic target" or a therapeutic interface in regenerative medicine and immunotherapy (Fan et al., 2020). Understanding this interface requires evaluating the holistic change in the host microenvironment rather than the inhibition or activation of a single enzyme or receptor.
Modulation of the host immune environment through the secretion of soluble paracrine factors, direct membrane-bound protein interactions (cell-cell contact), and the horizontal transfer of bioactive molecules (miRNA, proteins) via extracellular vesicles.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host immune system and microenvironment.